Nimacimab
Nimacimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Nimacimab is under investigation in clinical trial NCT03261739 (Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)).
| Trade Name | Nimacimab |
| Generic | Nimacimab |
| Nimacimab Other Names | Nimacimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Nimacimab
